Alfred M. Cohen, MD, FACS | Authors

DISCOUNT DRUG MART #2

393 ALEXIS DR

DISCOUNT DRUG MART #2

Articles

Commentary (Cohen): Radiation Therapy for Resectable Colon Cancer

February 02, 2006

Colon cancer is a major public health problem. The primary treatment is resection. For patients with early-stage disease, surgery results in excellent survival rates. In contrast, patients with locally advanced tumors arising in "anatomically immobile" segments of large bowel have a less satisfactory outcome, in part secondary to compromised surgical clearance. Patterns-of-failure analyses suggest that for tumors that invade adjacent organs, exhibit perforation or fistula, or are subtotally resected, local failure rates exceed 30%. Multiple single-institution retrospective studies have shown improved local control and possibly survival with the addition of external irradiation and/or intraoperative radiation. In contrast, a recent Intergroup trial failed to show any benefit by the addition of adjuvant radiation therapy combined with chemotherapy. Interpretation of this trial's results is handicapped by low patient accrual. With the advent of novel and more effective systemic therapies for metastatic colon cancer, current and future clinical research will address the efficacy of these agents in the adjuvant setting. Adjuvant radiation therapy should be considered in patients with colon cancer at high risk for local failure.

Commentary (Cohen): Are We Overtreating Some Patients With Rectal Cancer?

December 01, 2004

In this issue of ONCOLOGY, Dr.Rothenberger and colleagueshave collated clinicopathologicdata with the theme of local recurrenceand selective use of adjuvanttherapy. They conclude that the datasuggest we continue to overtreat somepatients with rectal cancer. As a generalization,I completely agree withthe authors. However, it is quite difficultto take outcomes data from largenumbers of patients and selectivelyapply the end results to the prospectivemanagement of an individualpatient with rectal cancer in the absenceof highly accurate preoperativestaging.

The Sentinel Node in Colorectal Carcinoma

May 01, 2002

The authors are to be complimented on a thoughtful and complete review of the application of the sentinel node paradigm to colorectal cancer. This paradigm is inherently quite different for colorectal cancer because, except for the occasional demonstration of variant anatomy, the technique will not alter the extent of surgery as it has done in melanoma and breast cancer.

Society of Surgical Oncology Practice Guidelines: Introductory Remarks

September 01, 1997

Thousands of practice guidelines/practice parameters have been published by various professional organizations. The American Medical Association,[1] American College of Physicians,[2,3] and others[4-6] have written extensively about

SSO Practice Guidelines: Introductory Remarks

August 01, 1997

Thousands of practice guidelines/practice parameters have been published by various professional organizations. The American Medical Association,[1] American College of Physicians,[2,3] and others[4-6] have written extensively about

SGO Practice Guidelines: Introductory Remarks

July 01, 1997

Thousands of practice guidelines/practice parameters have been published by various professional organizations. The American Medical Association,[1] American College of Physicians,[2,3] and others[4-6] have written extensively about

Colorectal Cancer Surgical Practice Guidelines

July 01, 1997

The Society of Surgical Oncology surgical practice guidelines focus on the signs and symptoms of primary cancer, timely evaluation of the symptomatic patient, appropriate preoperative evaluation for extent of disease, and role of the surgeon in

SSO Practice Guidelines: Introductory Remarks

June 01, 1997

The Agency for Health Care Policy and Research established a forum for quality and effectiveness in health care under which practice guidelines were to be evaluated. The groups involved in this forum turned to the Institute of Medicine to evaluate the